80 Therapeutical drug monitoring of piperacillin/tazobactam, given as continuous infusion to patients with cystic fibrosis
Gespeichert in:
| Autor*in: |
Öbrink-Hansen, K. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|
| Erschienen: |
2014 |
|---|
| Übergeordnetes Werk: |
Enthalten in: In vitro evaluation of synergistic effect of primary and tertiary amino groups in chitosan used as a non-viral gene carrier system - Gök, Mehmet Koray ELSEVIER, 2019, the official journal of the European Cystic Fibrosis Society, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:13 ; year:2014 ; pages:66 |
| Links: |
|---|
| DOI / URN: |
10.1016/S1569-1993(14)60216-2 |
|---|
| Katalog-ID: |
ELV027965341 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV027965341 | ||
| 003 | DE-627 | ||
| 005 | 20230623191957.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2014 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1016/S1569-1993(14)60216-2 |2 doi | |
| 028 | 5 | 2 | |a GBVA2014007000003.pica |
| 035 | |a (DE-627)ELV027965341 | ||
| 035 | |a (ELSEVIER)S1569-1993(14)60216-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 670 |q VZ |
| 084 | |a 35.80 |2 bkl | ||
| 100 | 1 | |a Öbrink-Hansen, K. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a 80 Therapeutical drug monitoring of piperacillin/tazobactam, given as continuous infusion to patients with cystic fibrosis |
| 264 | 1 | |c 2014 | |
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 700 | 1 | |a Hardlei, T.F. |4 oth | |
| 700 | 1 | |a Jensen-Fangel, S. |4 oth | |
| 700 | 1 | |a Brock, B. |4 oth | |
| 700 | 1 | |a Thomsen, M.K. |4 oth | |
| 700 | 1 | |a Petersen, E. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Gök, Mehmet Koray ELSEVIER |t In vitro evaluation of synergistic effect of primary and tertiary amino groups in chitosan used as a non-viral gene carrier system |d 2019 |d the official journal of the European Cystic Fibrosis Society |g Amsterdam [u.a.] |w (DE-627)ELV002341220 |
| 773 | 1 | 8 | |g volume:13 |g year:2014 |g pages:66 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/S1569-1993(14)60216-2 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 936 | b | k | |a 35.80 |j Makromolekulare Chemie |q VZ |
| 951 | |a AR | ||
| 952 | |d 13 |j 2014 |h 66 |y 13.2014, S66- | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
k ö h köh |
|---|---|
| matchkey_str |
brinkhansenkhardleitfjensenfangelsbrockb:2014----:0hrpuiadumntrnopprclitzbcagvnsotnosnuin |
| hierarchy_sort_str |
2014 |
| bklnumber |
35.80 |
| publishDate |
2014 |
| allfields |
10.1016/S1569-1993(14)60216-2 doi GBVA2014007000003.pica (DE-627)ELV027965341 (ELSEVIER)S1569-1993(14)60216-2 DE-627 ger DE-627 rakwb 610 610 DE-600 670 VZ 35.80 bkl Öbrink-Hansen, K. verfasserin aut 80 Therapeutical drug monitoring of piperacillin/tazobactam, given as continuous infusion to patients with cystic fibrosis 2014 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Hardlei, T.F. oth Jensen-Fangel, S. oth Brock, B. oth Thomsen, M.K. oth Petersen, E. oth Enthalten in Elsevier Science Gök, Mehmet Koray ELSEVIER In vitro evaluation of synergistic effect of primary and tertiary amino groups in chitosan used as a non-viral gene carrier system 2019 the official journal of the European Cystic Fibrosis Society Amsterdam [u.a.] (DE-627)ELV002341220 volume:13 year:2014 pages:66 https://doi.org/10.1016/S1569-1993(14)60216-2 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 35.80 Makromolekulare Chemie VZ AR 13 2014 66 13.2014, S66- 045F 610 |
| spelling |
10.1016/S1569-1993(14)60216-2 doi GBVA2014007000003.pica (DE-627)ELV027965341 (ELSEVIER)S1569-1993(14)60216-2 DE-627 ger DE-627 rakwb 610 610 DE-600 670 VZ 35.80 bkl Öbrink-Hansen, K. verfasserin aut 80 Therapeutical drug monitoring of piperacillin/tazobactam, given as continuous infusion to patients with cystic fibrosis 2014 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Hardlei, T.F. oth Jensen-Fangel, S. oth Brock, B. oth Thomsen, M.K. oth Petersen, E. oth Enthalten in Elsevier Science Gök, Mehmet Koray ELSEVIER In vitro evaluation of synergistic effect of primary and tertiary amino groups in chitosan used as a non-viral gene carrier system 2019 the official journal of the European Cystic Fibrosis Society Amsterdam [u.a.] (DE-627)ELV002341220 volume:13 year:2014 pages:66 https://doi.org/10.1016/S1569-1993(14)60216-2 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 35.80 Makromolekulare Chemie VZ AR 13 2014 66 13.2014, S66- 045F 610 |
| allfields_unstemmed |
10.1016/S1569-1993(14)60216-2 doi GBVA2014007000003.pica (DE-627)ELV027965341 (ELSEVIER)S1569-1993(14)60216-2 DE-627 ger DE-627 rakwb 610 610 DE-600 670 VZ 35.80 bkl Öbrink-Hansen, K. verfasserin aut 80 Therapeutical drug monitoring of piperacillin/tazobactam, given as continuous infusion to patients with cystic fibrosis 2014 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Hardlei, T.F. oth Jensen-Fangel, S. oth Brock, B. oth Thomsen, M.K. oth Petersen, E. oth Enthalten in Elsevier Science Gök, Mehmet Koray ELSEVIER In vitro evaluation of synergistic effect of primary and tertiary amino groups in chitosan used as a non-viral gene carrier system 2019 the official journal of the European Cystic Fibrosis Society Amsterdam [u.a.] (DE-627)ELV002341220 volume:13 year:2014 pages:66 https://doi.org/10.1016/S1569-1993(14)60216-2 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 35.80 Makromolekulare Chemie VZ AR 13 2014 66 13.2014, S66- 045F 610 |
| allfieldsGer |
10.1016/S1569-1993(14)60216-2 doi GBVA2014007000003.pica (DE-627)ELV027965341 (ELSEVIER)S1569-1993(14)60216-2 DE-627 ger DE-627 rakwb 610 610 DE-600 670 VZ 35.80 bkl Öbrink-Hansen, K. verfasserin aut 80 Therapeutical drug monitoring of piperacillin/tazobactam, given as continuous infusion to patients with cystic fibrosis 2014 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Hardlei, T.F. oth Jensen-Fangel, S. oth Brock, B. oth Thomsen, M.K. oth Petersen, E. oth Enthalten in Elsevier Science Gök, Mehmet Koray ELSEVIER In vitro evaluation of synergistic effect of primary and tertiary amino groups in chitosan used as a non-viral gene carrier system 2019 the official journal of the European Cystic Fibrosis Society Amsterdam [u.a.] (DE-627)ELV002341220 volume:13 year:2014 pages:66 https://doi.org/10.1016/S1569-1993(14)60216-2 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 35.80 Makromolekulare Chemie VZ AR 13 2014 66 13.2014, S66- 045F 610 |
| allfieldsSound |
10.1016/S1569-1993(14)60216-2 doi GBVA2014007000003.pica (DE-627)ELV027965341 (ELSEVIER)S1569-1993(14)60216-2 DE-627 ger DE-627 rakwb 610 610 DE-600 670 VZ 35.80 bkl Öbrink-Hansen, K. verfasserin aut 80 Therapeutical drug monitoring of piperacillin/tazobactam, given as continuous infusion to patients with cystic fibrosis 2014 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Hardlei, T.F. oth Jensen-Fangel, S. oth Brock, B. oth Thomsen, M.K. oth Petersen, E. oth Enthalten in Elsevier Science Gök, Mehmet Koray ELSEVIER In vitro evaluation of synergistic effect of primary and tertiary amino groups in chitosan used as a non-viral gene carrier system 2019 the official journal of the European Cystic Fibrosis Society Amsterdam [u.a.] (DE-627)ELV002341220 volume:13 year:2014 pages:66 https://doi.org/10.1016/S1569-1993(14)60216-2 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 35.80 Makromolekulare Chemie VZ AR 13 2014 66 13.2014, S66- 045F 610 |
| source |
Enthalten in In vitro evaluation of synergistic effect of primary and tertiary amino groups in chitosan used as a non-viral gene carrier system Amsterdam [u.a.] volume:13 year:2014 pages:66 |
| sourceStr |
Enthalten in In vitro evaluation of synergistic effect of primary and tertiary amino groups in chitosan used as a non-viral gene carrier system Amsterdam [u.a.] volume:13 year:2014 pages:66 |
| format_phy_str_mv |
Article |
| bklname |
Makromolekulare Chemie |
| institution |
findex.gbv.de |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
In vitro evaluation of synergistic effect of primary and tertiary amino groups in chitosan used as a non-viral gene carrier system |
| authorswithroles_txt_mv |
Öbrink-Hansen, K. @@aut@@ Hardlei, T.F. @@oth@@ Jensen-Fangel, S. @@oth@@ Brock, B. @@oth@@ Thomsen, M.K. @@oth@@ Petersen, E. @@oth@@ |
| publishDateDaySort_date |
2014-01-01T00:00:00Z |
| hierarchy_top_id |
ELV002341220 |
| dewey-sort |
3610 |
| id |
ELV027965341 |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV027965341</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623191957.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2014 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S1569-1993(14)60216-2</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014007000003.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV027965341</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1569-1993(14)60216-2</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">670</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.80</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Öbrink-Hansen, K.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">80 Therapeutical drug monitoring of piperacillin/tazobactam, given as continuous infusion to patients with cystic fibrosis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hardlei, T.F.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jensen-Fangel, S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Brock, B.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Thomsen, M.K.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Petersen, E.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Gök, Mehmet Koray ELSEVIER</subfield><subfield code="t">In vitro evaluation of synergistic effect of primary and tertiary amino groups in chitosan used as a non-viral gene carrier system</subfield><subfield code="d">2019</subfield><subfield code="d">the official journal of the European Cystic Fibrosis Society</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV002341220</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:13</subfield><subfield code="g">year:2014</subfield><subfield code="g">pages:66</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S1569-1993(14)60216-2</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.80</subfield><subfield code="j">Makromolekulare Chemie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">13</subfield><subfield code="j">2014</subfield><subfield code="h">66</subfield><subfield code="y">13.2014, S66-</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Öbrink-Hansen, K. |
| spellingShingle |
Öbrink-Hansen, K. ddc 610 ddc 670 bkl 35.80 80 Therapeutical drug monitoring of piperacillin/tazobactam, given as continuous infusion to patients with cystic fibrosis |
| authorStr |
Öbrink-Hansen, K. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV002341220 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 670 - Manufacturing |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 670 VZ 35.80 bkl 80 Therapeutical drug monitoring of piperacillin/tazobactam, given as continuous infusion to patients with cystic fibrosis |
| topic |
ddc 610 ddc 670 bkl 35.80 |
| topic_unstemmed |
ddc 610 ddc 670 bkl 35.80 |
| topic_browse |
ddc 610 ddc 670 bkl 35.80 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
t h th s j f sjf b b bb m t mt e p ep |
| hierarchy_parent_title |
In vitro evaluation of synergistic effect of primary and tertiary amino groups in chitosan used as a non-viral gene carrier system |
| hierarchy_parent_id |
ELV002341220 |
| dewey-tens |
610 - Medicine & health 670 - Manufacturing |
| hierarchy_top_title |
In vitro evaluation of synergistic effect of primary and tertiary amino groups in chitosan used as a non-viral gene carrier system |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV002341220 |
| title |
80 Therapeutical drug monitoring of piperacillin/tazobactam, given as continuous infusion to patients with cystic fibrosis |
| ctrlnum |
(DE-627)ELV027965341 (ELSEVIER)S1569-1993(14)60216-2 |
| title_full |
80 Therapeutical drug monitoring of piperacillin/tazobactam, given as continuous infusion to patients with cystic fibrosis |
| author_sort |
Öbrink-Hansen, K. |
| journal |
In vitro evaluation of synergistic effect of primary and tertiary amino groups in chitosan used as a non-viral gene carrier system |
| journalStr |
In vitro evaluation of synergistic effect of primary and tertiary amino groups in chitosan used as a non-viral gene carrier system |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2014 |
| contenttype_str_mv |
zzz |
| container_start_page |
66 |
| author_browse |
Öbrink-Hansen, K. |
| container_volume |
13 |
| class |
610 610 DE-600 670 VZ 35.80 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Öbrink-Hansen, K. |
| doi_str_mv |
10.1016/S1569-1993(14)60216-2 |
| dewey-full |
610 670 |
| title_sort |
80 therapeutical drug monitoring of piperacillin/tazobactam, given as continuous infusion to patients with cystic fibrosis |
| title_auth |
80 Therapeutical drug monitoring of piperacillin/tazobactam, given as continuous infusion to patients with cystic fibrosis |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
| title_short |
80 Therapeutical drug monitoring of piperacillin/tazobactam, given as continuous infusion to patients with cystic fibrosis |
| url |
https://doi.org/10.1016/S1569-1993(14)60216-2 |
| remote_bool |
true |
| author2 |
Hardlei, T.F. Jensen-Fangel, S. Brock, B. Thomsen, M.K. Petersen, E. |
| author2Str |
Hardlei, T.F. Jensen-Fangel, S. Brock, B. Thomsen, M.K. Petersen, E. |
| ppnlink |
ELV002341220 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth |
| doi_str |
10.1016/S1569-1993(14)60216-2 |
| up_date |
2024-07-06T17:35:35.644Z |
| _version_ |
1803852013261291520 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV027965341</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623191957.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2014 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S1569-1993(14)60216-2</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014007000003.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV027965341</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1569-1993(14)60216-2</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">670</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.80</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Öbrink-Hansen, K.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">80 Therapeutical drug monitoring of piperacillin/tazobactam, given as continuous infusion to patients with cystic fibrosis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hardlei, T.F.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jensen-Fangel, S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Brock, B.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Thomsen, M.K.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Petersen, E.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Gök, Mehmet Koray ELSEVIER</subfield><subfield code="t">In vitro evaluation of synergistic effect of primary and tertiary amino groups in chitosan used as a non-viral gene carrier system</subfield><subfield code="d">2019</subfield><subfield code="d">the official journal of the European Cystic Fibrosis Society</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV002341220</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:13</subfield><subfield code="g">year:2014</subfield><subfield code="g">pages:66</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S1569-1993(14)60216-2</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.80</subfield><subfield code="j">Makromolekulare Chemie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">13</subfield><subfield code="j">2014</subfield><subfield code="h">66</subfield><subfield code="y">13.2014, S66-</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.3990517 |